Abstract
Globalization, the modern lifestyle, immuno-suppressive agents, invasive surgical procedures, the loss of efficacies of existing drugs, and multidrug resistance are some of the factors used to explain the rise in fungal infections in recent years. Significant advances have been made in attempts to replace existing antifungal schedules, especially with synthetic targets. The identification of other platforms for drug discovery is now entrenched in research programs across the globe. Plants offer significant benefits owing to their numerical superiority, exceedingly broad chemical basis and appealing sustainability characteristics. Furthermore, plants have a long and rich historical association with traditional approaches towards fungal diseases. These have in numerous instances served as markers in the bioassay-guided identification of the active constituents. Although the plant family Amaryllidaceae is conventionally associated with cancer and motor-neuron disease chemotherapies, around 30 of its species have been examined for antifungal activities with microgram per millilitre inhibitory activities detected in several instances. This review focuses on the nearly 40 constituents from the family, mainly isoquinoline alkaloids, w...Continue Reading
References
Dec 1, 1975·FEBS Letters·A JimenezD Vazquez
Jun 1, 1996·Journal of Ethnopharmacology·A K JägerJ van Staden
Oct 5, 2001·Journal of Ethnopharmacology·C W Fennell, J van Staden
May 21, 2003·Antonie van Leeuwenhoek·Silvano OnofriIsabella Garuccio
May 13, 2004·Journal of Ethnopharmacology·Michael Heinrich, Hooi Lee Teoh
Jul 29, 2004·Phytochemistry·Antonio EvidenteAndrea Motta
Nov 4, 2004·Biochemical and Biophysical Research Communications·Kin Tak Chu, Tzi Bun Ng
Dec 3, 2005·International Journal of Antimicrobial Agents·T P Tim Cushnie, Andrew J Lamb
Jun 15, 2006·Journal of Medical Microbiology·D A EnochN M Brown
May 21, 2008·Chemical Reviews·Alexander Kornienko, Antonio Evidente
Oct 23, 2008·Lipids·Zhi-Ping WuXu Feng
Sep 3, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jerald J Nair, Johannes van Staden
Dec 19, 2013·Journal of Microbiology and Biotechnology·Jin-Wen ShenChun-Feng Zheng
Oct 24, 2014·BMC Complementary and Alternative Medicine·Francesca BonviciniGiovanna Angela Gentilomi
Nov 1, 2015·BMC Microbiology·Federica PerdoniElisa Borghi
Oct 27, 2016·Natural Product Reports·Zhong Jin
Oct 17, 2017·Bioorganic & Medicinal Chemistry Letters·Jerald J NairJohannes van Staden
Citations
Jul 31, 2020·Medicinal Research Reviews·Xiao-Fei ShangKuo-Hsiung Lee
Oct 21, 2020·Pharmaceuticals·Olga BabichSvetlana Ivanova
Aug 17, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mridul RoyJing Liu